GENEVA--(BUSINESS WIRE)--iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumors, announced today that it will present Phase Ib data on its lead pipeline ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results